Telmisartan and Insulin Resistance in HIV (TAILoR): protocol for a dose-ranging phase II randomised open-labelled trial of telmisartan as a strategy for the reduction of insulin resistance in HIV-positive individuals on combination antiretroviral therapy. (2015)

First Author: Pushpakom SP
Attributed to:  MRC North West Hub for Trials Methodology Research funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2015-009566

PubMed Identifier: 26474943

Publication URI: http://europepmc.org/abstract/MED/26474943

Type: Journal Article/Review

Volume: 5

Parent Publication: BMJ open

Issue: 10

ISSN: 2044-6055